Essex Savings Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $558K | Buy |
4,611
+85
| +2% | +$10.3K | 0.13% | 144 |
|
2025
Q1 | $505K | Buy |
4,526
+591
| +15% | +$65.9K | 0.12% | 150 |
|
2024
Q4 | $383K | Buy |
3,935
+72
| +2% | +$7.01K | 0.09% | 178 |
|
2024
Q3 | $444K | Buy |
3,863
+1,200
| +45% | +$138K | 0.11% | 162 |
|
2024
Q2 | $284K | Sell |
2,663
-611
| -19% | -$65K | 0.08% | 203 |
|
2024
Q1 | $331K | Hold |
3,274
| – | – | 0.1% | 180 |
|
2023
Q4 | $331K | Buy |
3,274
+719
| +28% | +$72.6K | 0.1% | 179 |
|
2023
Q3 | $260K | Hold |
2,555
| – | – | 0.09% | 184 |
|
2023
Q2 | $258K | Sell |
2,555
-64
| -2% | -$6.46K | 0.09% | 192 |
|
2023
Q1 | $241K | Buy |
2,619
+14
| +0.5% | +$1.29K | 0.08% | 198 |
|
2022
Q4 | $236K | Sell |
2,605
-354
| -12% | -$32.1K | 0.08% | 201 |
|
2022
Q3 | $224K | Buy |
2,959
+380
| +15% | +$28.8K | 0.09% | 188 |
|
2022
Q2 | $218K | Sell |
2,579
-2
| -0.1% | -$169 | 0.08% | 193 |
|
2022
Q1 | $227K | Sell |
2,581
-33
| -1% | -$2.9K | 0.08% | 205 |
|
2021
Q4 | $228K | Sell |
2,614
-8
| -0.3% | -$698 | 0.08% | 199 |
|
2021
Q3 | $242K | Sell |
2,622
-27
| -1% | -$2.49K | 0.09% | 186 |
|
2021
Q2 | $234K | Hold |
2,649
| – | – | 0.09% | 193 |
|
2021
Q1 | $227K | Sell |
2,649
-151
| -5% | -$12.9K | 0.1% | 178 |
|
2020
Q4 | $264K | Sell |
2,800
-178
| -6% | -$16.8K | 0.12% | 160 |
|
2020
Q3 | $259K | Hold |
2,978
| – | – | 0.13% | 158 |
|
2020
Q2 | $261K | Sell |
2,978
-1,224
| -29% | -$107K | 0.16% | 141 |
|
2020
Q1 | $347K | Sell |
4,202
-176
| -4% | -$14.5K | 0.25% | 106 |
|
2019
Q4 | $415K | Hold |
4,378
| – | – | 0.21% | 110 |
|
2019
Q3 | $381K | Sell |
4,378
-1,254
| -22% | -$109K | 0.2% | 108 |
|
2019
Q2 | $514K | Buy |
5,632
+851
| +18% | +$77.7K | 0.18% | 115 |
|
2019
Q1 | $412K | Buy |
4,781
+662
| +16% | +$57K | 0.23% | 91 |
|
2018
Q4 | $317K | Buy |
+4,119
| New | +$317K | 0.2% | 95 |
|